Active surveillance for the management of prostate cancer in a contemporary cohort (pages 2664–2670)
Marc A. Dall'Era, Badrinath R. Konety, Janet E. Cowan, Katsuto Shinohara, Frank Stauf, Matthew R. Cooperberg, Maxwell V. Meng, Christopher J. Kane, Nanette Perez, Viraj A. Master and Peter R. Carroll
Version of Record online: 23 APR 2008 | DOI: 10.1002/cncr.23502
Selected individuals with early-stage prostate cancer may be candidates for active surveillance. Prostate-specific antigen density at diagnosis and rise in Gleason score on repeat biopsy were found to be associated significantly with the receipt of secondary treatment.